Neuroblastoma Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Neuroblastoma Market Analysis, Market Size, Epidemiology,
Leading Companies and Competitive Analysis by DelveInsight
(Albany, US) DelveInsight has launched a new report on "Neuroblastoma
Market Insights, Epidemiology, and Market Forecast-2030".
DelveInsight's "Neuroblastoma Market Insights, Epidemiology,
and Market Forecast-2030" report delivers an in-depth
understanding of the Neuroblastoma, historical and forecasted epidemiology as
well as the Neuroblastoma market trends in the United States, EU5 (Germany,
Spain, Italy, France, and United Kingdom) and Japan.
·
According to DelveInsight, total Incident
population of Neuroblastoma in the seven major markets were observed to be more
than 1,500 in 2017
·
DelveInsight’s estimate suggest higher incidence
of neuroblastoma in the United States, as compared to EU-5 countries and Japan,
with 629 Incident population in 2017. Furthermore, the incidence rate of
neuroblastoma is increasing at a very slow rate in the United States, has
stabilized in the EU5 and in decreasing in Japan for the forecasted period,
i.e. 2017–2030.
·
As per DelveInsight’s analyst, among the
European countries, France has the highest Incident population of Neuroblastoma
with 156 cases, followed by the United Kingdom which has Incident population of
147 in 2017. On the other hand, Spain has the lowest Incident population of 90 cases
in 2017.
·
Furthermore, according to DelveInsight’s
analyst, Japan witnessed more than 250 incident cases of neuroblastoma in 2017.
View Report: https://www.delveinsight.com/report-store/neuroblastoma-market
Request Sample: https://www.delveinsight.com/sample-request/neuroblastoma-market
- The
Neuroblastoma report covers the descriptive overview of Neuroblastoma,
explaining its causes, signs and symptoms, pathophysiology, diagnosis and
currently available therapies
- Comprehensive
insight has been provided into the Neuroblastoma epidemiology and
treatment in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for
Neuroblastoma are provided, along with the assessment of new therapies,
which will have an impact on the current treatment landscape
- A
detailed review of Neuroblastoma market; historical and forecasted is
included in the report, covering drug outreach in the 7MM
- The
Neuroblastoma report provides an edge while developing business
strategies, by understanding trends shaping and driving the global
Neuroblastoma market
View Report: https://www.delveinsight.com/report-store/neuroblastoma-market
Request Sample: https://www.delveinsight.com/sample-request/neuroblastoma-market
Neuroblastoma
is an embryonal malignancy of the sympathetic nervous system arising from
neuroblasts (pluripotent sympathetic cells). It is derived from two words i.e.
“neuro” means nerves and “blastoma” refers to the tumor affecting the immature
or developing cells. It originates in the adrenal medulla and paraspinal or
periaortic regions where sympathetic nervous system tissue is present.
Stages of neuroblastoma determine the extent of spread of
the tumor in the patients, and the disease is staged on the basis of results of
physical exams, imaging tests, and biopsies of the main tumor and other
tissues. Staging of neuroblastoma is based on two classification systems:
International Neuroblastoma Staging System (INSS) and International
Neuroblastoma Risk Group Staging System (INRGSS).
Neuroblastoma is most common in very young children, but it
is rare in children over the age of 10 years.
Approximately 1% to 2% of patients with neuroblastoma
inherit an increased risk of developing neuroblastoma from their parents.
View Report: https://www.delveinsight.com/report-store/neuroblastoma-market
Request Sample: https://www.delveinsight.com/sample-request/neuroblastoma-market
·
Y-MABS Therapeutics Inc
·
Autolus Therapeutics
·
Clarity Pharmaceuticals
·
EUSA Pharma
·
United Therapeutics Corp
·
And Many Others
·
Naxitamab
·
Omburtamab
·
AUTO6NG
·
SARTATE
·
Qarziba
·
Unituxin
·
And Many Others
View Report: https://www.delveinsight.com/report-store/neuroblastoma-market
Request Sample: https://www.delveinsight.com/sample-request/neuroblastoma-market
1. Key Insights
2. Executive Summary
of Neuroblastoma
3. Competitive
Intelligence Analysis for Neuroblastoma
4. Neuroblastoma:
Market Overview at a Glance
5. Neuroblastoma:
Disease Background and Overview
6. Patient Journey
7. Neuroblastoma
Epidemiology and Patient Population
8. Treatment
Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of
Neuroblastoma Treatment
11. Marketed
Products
12. Emerging
Therapies
13. Neuroblastoma:
Seven Major Market Analysis
14. Attribute
analysis
15. 7MM: Market
Outlook
16. Access and
Reimbursement Overview of Neuroblastoma
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight
Capabilities
22. Disclaimer
23. About DelveInsight
View Report: https://www.delveinsight.com/report-store/neuroblastoma-market
Request Sample: https://www.delveinsight.com/sample-request/neuroblastoma-market
Comments
Post a Comment